An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...

Beneficiaries of plans that covered fewer than the median number of DMTs in the past year were more likely to have a relapse, a study shows.

The vaccine ELI-002 2P showed favorable relapse-free survival and overall survival in patients with pancreatic and colorectal ...

A small study finds that an off-the-shelf vaccine candidate by Elicio Therapeutics boosted immune response in pancreatic ...

High rates of early relapse following electroconvulsive therapy (ECT) are typically reported in the literature. Current treatment guidelines offer little information to clinicians on the optimal ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...

This report details how pleomorphic breast carcinoma evaded initial treatment protocols and spread to 70% of the thorax ...

Finding out how “seeds” of breast cancer hide themselves in bones and how to stop them “waking up” could offer hope of an end ...